Original Research

miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib

Wang L, En H, Yang L, Zhang Y, Sun B, Gao J

OncoTargets and Therapy 2019, 12:6825-6838

Published Date: 21 August 2019